Cargando…
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
Autores principales: | Bonnet, Nicolas, Bourgoin, Lucie, Biver, Emmanuel, Douni, Eleni, Ferrari, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927940/ https://www.ncbi.nlm.nih.gov/pubmed/36787261 http://dx.doi.org/10.1172/JCI169317 |
Ejemplares similares
-
RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]
Publicado: (2022) -
New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis
por: Papadaki, Maria, et al.
Publicado: (2019) -
N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis
por: Kim, Hae-Rim, et al.
Publicado: (2019) -
Corrigendum to “Comparative Sensitivity Analysis of Muscle Activation Dynamics”
por: Rockenfeller, Robert, et al.
Publicado: (2017) -
Inhibition of RANKL- induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium- particle- induced osteolysis
Publicado: (2018)